Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
作者信息
Stepkowski S M, Chen H, Daloze P, Kahan B D
机构信息
University of Texas Medical School, Division of Immunology and Organ Transplantation, Houston 77030.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 1):507-8.
PMID:1990602
Abstract
摘要
相似文献
1
Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
Transplant Proc. 1991 Feb;23(1 Pt 1):507-8.
2
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Transplant Proc. 1991 Dec;23(6):3262-4.
3
Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
Transplant Proc. 1993 Feb;25(1 Pt 1):719-20.
4
Reversal of ongoing rejection of allografts by rapamycin.
Transplant Proc. 1991 Aug;23(4):2241-2.
5
Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
Transplant Proc. 1992 Jun;24(3):892-3.
6
The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat.
Transplant Proc. 1991 Aug;23(4):2239-40.
7
Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Transplant Proc. 1994 Oct;26(5):3053-5.
8
Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
Transplant Proc. 1993 Feb;25(1 Pt 1):729.
9
Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Transplant Proc. 1992 Oct;24(5):1669-70.
10
Effect of FK 506 and cyclosporine on heart allograft survival in rats.
Transplant Proc. 1991 Feb;23(1 Pt 1):529-30.
引用本文的文献
1
I-2190A is a potent immunosuppressive drug for vascularized heart transplantation in rats.
J Tongji Med Univ. 1998;18(1):37-8, 41. doi: 10.1007/BF02888277.
Zotero 插件